Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

11160	Companies
246378	Keywords
174366	Articles
133071	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/08/2025 at 07:00, 1 year 3 months ago

Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025
Biophytis SA announces participation in ARC 2025 to present results of BIO101 in sarcopenia at the World Aging & Rejuvenation Conference, aiming to strengthen scientific visibility and expand in the longevity market

Sarcopenia Biophytis SA BIO101 Longevity Market ARC 2025
BRIEF

published on 07/07/2025 at 07:05, 1 year 3 months ago

Biophytis Aims to Address Muscle Loss in Obesity Market

Biophytis BIO101 Muscle Preservation GLP-1 Therapies Obesity Market
REGULATED PRESS RELEASE

published on 07/07/2025 at 07:00, 1 year 3 months ago

Obesity: Biophytis Charts Its Course Toward a Booming Market
Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market

BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
BRIEF

published on 07/03/2025 at 07:05, 1 year 3 months ago

Biophytis Showcases Innovations at BIO International 2025

Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 1 year 3 months ago

Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025
Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact

Innovations Longevity Obesity Muscle Health Biophy(s
BRIEF

published on 06/30/2025 at 22:35, 1 year 3 months ago

Biophytis Delays Publication of 2024 Annual Financial Statements

Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 1 year 3 months ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
PRESS RELEASE

published on 06/30/2025 at 22:29, 1 year 3 months ago

Information on the Annual Financial Statements
Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments

Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF

published on 06/19/2025 at 23:05, 1 year 3 months ago

Biophytis Temporarily Suspends Share Trading

Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension
REGULATED PRESS RELEASE

published on 06/19/2025 at 23:00, 1 year 3 months ago

Biophytis announces the temporary suspension of the trading of its shares
Biophytis announces temporary suspension of trading shares on Euronext due to delayed financial report. Expected to resume after report publication. Company info included

Biophytis Euronext Trading Financial Report Suspension

Accesswire

Published on 10/12/2026 at 22:01, 5 hours 16 minutes ago

Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 12 hours 17 minutes ago

Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 14 hours 17 minutes ago

U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 22 hours ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 3 days 1 hour ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 10/12/2026 at 20:30, 6 hours 47 minutes ago

Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 6 hours 47 minutes ago

Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 7 hours 12 minutes ago

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 8 hours 7 minutes ago

Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 18:45, 8 hours 32 minutes ago

Fraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth

Les Echos

Published on 10/12/2026 at 17:59, 9 hours 18 minutes ago

Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 9 hours 32 minutes ago

Weekly share buyback
Published on 10/12/2026 at 17:45, 9 hours 32 minutes ago

Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 11 hours 30 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Published on 10/12/2026 at 15:12, 12 hours 5 minutes ago

Statement of transactions in own shares from October 5, 2026 to October 9, 2026

View all LES ECHOS COMFI WIRE